Status:
COMPLETED
Growth Hormone Treatment in Short Children Born Small for Gestational Age
Lead Sponsor:
Eli Lilly and Company
Conditions:
Infant, Small for Gestational Age
Eligibility:
All Genders
3+ years
Phase:
PHASE3
Brief Summary
Comparison of 2 different doses of human growth hormone treatment on change in height after 1 and 2 years of treatment.
Eligibility Criteria
Inclusion
- Born small for gestational age
- actual body height less than or equal -3 SDS
- chronological age greater than 3 years
Exclusion
- Growth hormone deficiency
- any defined syndromal disease
- Diabetes mellitus
Key Trial Info
Start Date :
December 1 2002
Trial Type :
INTERVENTIONAL
End Date :
June 1 2007
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT00191529
Start Date
December 1 2002
End Date
June 1 2007
Last Update
June 15 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Cologne, Germany